Sort
24,576 grants matching “microbiome”
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
$622,831Robert S Brown · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · DK
Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progression
$622,803Sabita Roy · University Of Miami School Of Medicine · R01 · FY2020 · DA
Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progression
$622,803Sabita Roy · University Of Miami School Of Medicine · R01 · FY2019 · DA
Prioritization and Bioactivity Characterization of Novel Bile Acids Produced by the Microbiome
$622,750Robert Andrew Quinn · Michigan State University · R01 · FY2025 · DK
Boston University/Lata Medical Research Foundation Global Network for Women's Children's Health Research Unit
$622,651Patricia L Hibberd · Boston University Medical Campus · UG1 · FY2023 · HD
Modulation of Viral Antigen Presentation in the Lung
$622,562Anna Karolina Palucka · Jackson Laboratory · U19 · FY2019 · AI
Role of Microbial dysbiosis and altered metabolomics in the context of Opioid abuse and ART in HIV disease progression
$622,513Sabita Roy · University Of Miami School Of Medicine · R01 · FY2018 · DA
Genetic determinants of Bacteroides vulgatus colonization fitness and host inflammatory responses
$622,416John F Rawls · Duke University · R01 · FY2024 · DK
Genomic Analysis of Immunity and Lung Inflammation in HIV Infection
$622,323Homer L Twigg · Indiana University Indianapolis · U01 · FY2014 · HL
Defining the impact of developmental herbicide exposures on gut microbiome physiology and interactions with health
$622,235Christopher A Gaulke · University Of Illinois At Urbana-Champaign · R01 · FY2025 · ES
Chemistry Core
$622,210Timothy S Bugni · University Of Wisconsin-Madison · U19 · FY2021 · AI
Olfactory Receptor 558 (OLFR558) Ligands and Blood Pressure Regulation
$622,180Jennifer L Pluznick · Johns Hopkins University · R01 · FY2025 · DK
Azithromycin as adjunctive treatment for uncomplicated severe acute malnutrition: the AMOUR trial
$622,142Catherine Elizabeth Oldenburg · University Of California, San Francisco · R01 · FY2024 · HD
Determinants of H. influenzae Virulence in Otitis Media
$622,078Lauren O Bakaletz · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · DC
Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis
$622,049Karen R Jonscher · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · DK
Early life determinants of cardiometabolic health from birth to adolescence amongst HIV-exposed and unexposed South African children
$622,025Jennifer Ann Pellowski · Brown University · R01 · FY2022 · HD
Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis
$621,994Karen R Jonscher · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2024 · DK
Validation of a salivary miRNA diagnostic test for autism spectrum disorder
$621,969Frank A Middleton · Quadrant Biosciences, Inc. · R42 · FY2020 · MH
Collaborative Proposal: RoL: The Scale of Resistance: Landscape to Microbiome-level Processes Regulating Acquired Disease Resistance
$621,963Carlos G Becker · University Of Alabama Tuscaloosa · · FY2020 · BIO
Transition to a Western diet and cardiometabolic risk: biomarkers derived from the microbiome
$621,862Penny Gordon-Larsen · Univ Of North Carolina Chapel Hill · R01 · FY2017 · DK
Rapid AST through Metabolic Imaging at Single Cell Level
$621,858Ji-Xin Cheng · Boston University (Charles River Campus) · R01 · FY2024 · AI
Filaggrin Expression in Atopic Dermatitis: Regulation and Impact on Disease Progression
$621,811Leah Claire Kottyan · Cincinnati Childrens Hosp Med Ctr · U19 · FY2025 · AI
Diabetes Progression with Metabolomic Profiling in Starr County Mexican Americans
$621,803Goo Jun · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · DK
Biofilm Elimination and Caries Prevention using Multifunctional Nanocatalysts
$621,731Hyun Koo · University Of Pennsylvania · R01 · FY2021 · DE
A Phase II randomized controlled trial to evaluate the role of BB-12 in antibiotic-associated diarrhea and its effects on the gut microbiome
$621,668Daniel J Merenstein · Georgetown University · R01 · FY2019 · HD